Anti-Human GLG1 Therapeutic Antibody
The glucagon-specific antibody is linked to a GLP-1 which results in a GLP-1 compound/glucagon antibody, the antibody have glucagon neutralizing activity and the compound can be used in the treatment of diabetes, impaired glucose tolerance, insulin resistance, various lipid disorders, obesity, cardiovascular disease and bone disorders.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-0609CLV |
| Pricing | Inquiry |
| Host | Human |
| Target | GLP-1 |